Selected Publications


Grove TB, Lasagna CA, Martínez-Cancino R, Pamidighantam P, Deldin PJ, Tso IF. (2021). Neural oscillatory abnormalities during gaze processing in schizophrenia: Evidence of reduced theta phase consistency and inter-regional theta-gamma coupling. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 6(3), 370-379.

Lehet M, Tso IF, Neggers SFW, Thompson IA, Yao B, Kahn RS, Thakkar KN. (2021). Altered effective connectivity within an oculomotor control network in individuals with schizophrenia. NeuroImage: Clinical, 31: 102764 .

Lehet M, Tso IF, Park S, Neggers SFW, Thompson IA, Kahn RS, Thakkar KN. (2021). Altered effective connectivity within an oculomotor control network in unaffected relatives of individuals with schizophrenia. Brain Sciences,11:1128.

Tso IF, Angstadt M, Rutherford S, Peltier S, Diwadkar VA, Taylor SF. (2021). Dynamic causal modeling of eye gaze processing in schizophrenia. Schizophrenia Research, 229: 112-121.


Bornheimer LA, Li J, Im V, Taylor M, Himle JA. (2020). The role of social isolation in the relationships between psychosis and suicidal ideation. Clinical Social Work Journal, 48, 54-62.

Bornheimer LA, Tarrier N, Brinen AP, Dwyer M, Li J, Himle J. (2020). Longitudinal predictors of stigma in first-episode psychosis (FEP): Mediating effects of depression. Early Intervention in Psychiatry, 1-8.

Tso IF, Lasagna CA, Fitzgerald KD, Colombi C, Sripada C, Peltier S, Johnson TD, Thakkar KN. (2020). Disrupted eye gaze perception as a biobehavioral marker of social dysfunction: An RDoC investigation. Journal of Psychiatry and Brain Science, 5(5):e200021.

Hirjak D, Northoff G, Taylor SF, Wolf RC. (2020). GABA-B receptor, clozapine, and catatonia—a complex triad, Molecular Psychiatry.


Bornheimer LA, Zhang A, Tarrier N, Li J, Ning Y, Himle J. (2019). Depression moderates the relationships between hallucinations, delusions, and suicidal ideation: The cumulative effect of experiencing both hallucinations and delusions. Journal of Psychiatric Research, 116, 166-171.

Burton CZ, Tso IF, Carrión RE, Niendam T, Adelsheim S, Auther AM, Cornblatt BA, Carter CS, Melton R, Sale TG, Taylor SF, & McFarlane WR. (2019). Baseline psychopathology and relationship to longitudinal functional outcome in attenuated and early first episode psychosis. Schizophrenia Research, 212:157-162.

Cassady K, Gagnon H, Lalwani P, Simmonite M, Foerster B, Park D, Petrou M, Taylor SF, Weissman DH, Seidler RD, and Polk TA. (2019). Sensorimotor network segregation declines with age and is linked to GABA and sensorimotor performance. NeuroImage, 186:234-244. PMCID:PMC6338503.

Kraal AZ, Moll AC, Arvanitis NR, Ward KM, Dougherty RJ, Grove TB, Burghardt KJ, Ellingrod VL (2019). Metabolic syndrome is negatively associated with cognition among endothelial nitric oxide synthase (eNOS) carriers in schizophrenia-spectrum disorders. Journal of Psychiatric Research.

Guo JY, Niendam T, Auther AM, Carrion RE, Cornblatt BA, Ragland JD, Adelsheim S, Calkins R, Sale TG, Taylor SF, McFarlane WR, Carter CS. (2020). Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study, Psychological Medicine, 50(13):2230-2239. PMCID: 31507256.

Lalwani P, Gagnon H, Cassady K, Simmonite M, Peltier S, Seidler RD, Taylor SF, Weissman DH, Polk TA. (2019). Neural distinctiveness declines with age in auditory cortex and is associated with auditory GABA levels, NeuroImage, 201, 116033. PMCID: PMC6765441.

Taylor SF, Grove TB, Ellingrod VL, Tso IF. (2019). The fragile brain: Stress vulnerability, negative affect and GABAergic neurocircuits in psychosis. Schizophrenia Bulletin, 45(6):1170-1183.


Burton CZ, Ryan KA, Kamali M, Marshall DF, Harrington G, McInnis MG, Tso IF. (2018). Psychosis in bipolar disorder: Does it represent a more ‘severe’ illness? Bipolar Disorders, 20(1): 18-26.

Carrion RE, Walder DJ, Auther A, McLaughlin D, Zyla H, Adelsheim S, Calkins R, Carter CS, McFarland B, Melton R, Niendam T, Ragland JD, Sale TG, Taylor SF, McFarlane WR, Cornblatt BA. (2018). From the Psychosis Prodrome to the First-Episode of Psychosis: No Evidence of a Cognitive Decline. Journal of Psychiatric Research, 96:231-238. PMCID: PMC7663810.

Grove TB, Yao B, Mueller SA, McLaughlin M, Ellingrod V, McInnis MG, Taylor SF, Deldin PJ, Tso IF. (2018). A Bayesian model comparison approach to test the specificity of visual integration impairment in schizophrenia or psychosis. Psychiatry Research, 265:271-278.

Yao B, Mueller SA, Grove TB, McLaughlin M, Thakkar KN, Ellingrod V, McInnis MG, Taylor SF, Deldin PJ, Tso IF. (2018). Eye gaze perception in bipolar disorder: Self-referential bias but intact perceptual sensitivity. Bipolar Disorders, 20(1): 60-69.


Lynch S, McFarlane WR, Joly B, Adelsheim S, Auther A, Cornblatt BA, Migliorati M, Ragland JD, Sale T, Spring E, Calkins R, Carter CS, Jaynes R, Taylor SF, Downing D, Early Detection. (2016). Intervention and Prevention of Psychosis Program: Community Outreach and Early Identification at Six U.S. Sites. Psychiatric Services, 67(5):510-6.

Tso IF, Taylor SF, Grove TB, Niendam T, Adelsheim S, Auther A, Cornblatt B, Carter CS, Calkins R, Ragland D, Sale T, McFarlane WR. (2017). Factor analysis of the Scale of Prodromal Symptoms: Data from the Early Detection and Intervention for the Prevention of Psychosis Program (EDIPPP). Early Intervention in Psychiatry, 11(1): 14–22.


Carrión RE, Cornblatt BA, Burton CZ, Tso IF, Auther A, Adelsheim S, Carter CS, Calkins R, Taylor SF, McFarlane WR. (2016). Personalized prediction of psychosis: External validation of the NAPLS 2 Psychosis Risk Calculator with the EDIPPP project. American Journal of Psychiatry, 173(10), 989-996.

Grove TB, Burghardt K, Taylor SF, Ellingrod VL (2016). Oxytocin receptor methylation and cognition in psychotic disorders. Molecular Neuropsychiatry, 2, 151-160.

Grove TB, Tso IF, Chun J, Mueller SA, Taylor SF, Ellingrod V, McInnis MG, Deldin PJ. (2016). Negative affect predicts social functioning across schizophrenia and bipolar disorder: Findings from an integrated analysis. Psychiatry Research, 243, 198-206.


Ellingrod VL, Grove TB, Burghardt KB, Taylor SF, Dalack G (2015). The effect of folate supplementation and genotype on cardiovascular and epigenetic measures in schizophrenia subjects. npj Schizophrenia.

Grove TB, Taylor SF, Dalack G, Ellingrod V (2015). Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders. Schizophrenia Research, 164(1-3), 115-121.

McFarlane WR, Levin B, Travis L, Lucas FL, Lynch S, Verdi M, Williams D, Adelsheim S, Calkins R, Carter CS, Cornblatt B, Taylor SF, Author AM, McFarland B, Melton R, Migliorati M, Niendam T, Ragland JD, Sale T, Salvador M, Spring L. (2015). Clinical and functional outcomes after 2 years in the national Early Detection and Intervention for the Prevention of Psychosis effectiveness trial. Schizophrenia Bulletin, 41:30-43. PMCID: PMC4266296.

Taylor SF, Tso IF. (2015). GABA abnormalities in schizophrenia: A methodological review of in vivo studies. Schizophrenia Research, 167(1-3): 84-90.

Tso IF, Calwas AM, Chun J, Mueller S, Taylor SF, Deldin PJ. (2015). Altered attentional and perceptual processes as indexed by N170 during gaze perception in schizophrenia: Relationship with perceived threat and paranoid delusions. Journal of Abnormal Psychology, 124(3):519-531.

Tso IF, Fang Y, Phan KL, Welsh RC, Taylor SF. (2015). Abnormal GABAergic function and face processing in schizophrenia: A pharmacologic-fMRI study. Schizophrenia Research, 168:338-344.


Bly MJ, Taylor SF, Dalack G, Pop-Busui R, Burghardt KJ, Evans SJ, McInnis MI, Grove TB, Borook RD, Zollner SK, Ellingrod VL. (2014). Metabolic Syndrome In Bipolar Disorder and Schizophrenia: Dietary and Lifestyle Factors Compared to the General Population. Bipolar Disorders, 16:277-88. PMCID: PMC4023536.

Burghardt K, Bly M, Grove TB, Ellingrod, V (2014). Endothelial nitric oxide synthetase genetic variants, metabolic syndrome and endothelial function in schizophrenia. Journal of Psychopharmacology, 28(4), 349-356.

Taylor SF, Demeter E, Phan KL, Tso IF, Welsh RC. (2014). Abnormal GABAergic function and negative affect in schizophrenia. Neuropsychopharmacology, 39(4):1000-1008.

Tso IF, Carp J, Taylor SF, Deldin PJ. (2014). Role of visual integration in gaze perception and emotional intelligence in schizophrenia. Schizophrenia Bulletin, 40(3):617-625.

Tso IF, Grove TB, Taylor SF. (2014). Differential hedonic experience and behavioral activation in schizophrenia and bipolar disorder. Psychiatry Research, 219(3):470-476.

Tso IF, Taylor SF, Grove TB, Adelsheim S, Cornblatt B, Carter CS, Calkins R, McFarlane WR (2014). Factor structure of the prodromal symptoms: Sample from the Early Detection and Intervention for the Prevention of Psychosis Program. Early Intervention in Psychiatry.


Chun J, Karim Z, Marzinzik F, Kamali M, O’Donnell L, Tso IF, Manschreck T, McInnis M, Deldin PJ. (2013). Can P300 distinguish among schizophrenia, schizoaffective, and bipolar disorders? An ERP study on response inhibition. Schizophrenia Research, 151(1-3):175-184.

Demeter E, Guthrie SK, Taylor SF, Sarter M, Lustig, C. (2013). Increased distractor vulnerability but preserved vigilance in patients with schizophrenia: Evidence from a translational sustained attention task, Schizophrenia Research, 144:136-41.


Burghardt KJ, Pop-Busui R, Bly M, Grove T, Taylor SF, Ellingrod VL. (2012). The Influence of the Brain-Derived Neurotropic Factor Val66Met -Genotype and HMG-CoA Reductase Inhibitors on Insulin Resistance in the Schizophrenia and Bipolar Populations. Clinical and Translational Science, 5:486-490.

Ellingrod VL, Taylor SF, Dalack G, Grove TB, Bly MJ, Brook RD, Zoellner SK, Pop-Busui R. (2012). Risk Factors Associated with Metabolic Syndrome in Bipolar and Schizophrenia Subjects Treated With Antipsychotics: The Role of Folate Pharmacogenetics. Journal of Clinical Psychopharmacology, 32: 261-5. PMCID: PMC3622480.

Lott S, Burghardt P, Burghardt K, Bly M, Grove TB, Ellingrod V (2012). The influence of metabolic syndrome, physical activity, and genotype on cathechol-o-methyl transferase promoter-region methylation in schizophrenia. The Pharmacogenomics Journal, 1-8.

Sarter M, Lustig C, Taylor SF. (2012). Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments. Psychopharmacology, 62:1544-1533.

Taylor SF, Kang J, Brege IS, Tso IF, Hosanager A, Johnson TD. (2012). Meta-analysis of functional imaging studies of emotion perception and experience in schizophrenia. Biological Psychiatry, 71:136-145.

Taylor SF, MacDonald AW. (2012). Brain Mapping Biomarkers of Socio-Emotional Processing in Schizophrenia. Schizophrenia Bulletin, 38:73-80. PMCID: PMC3245598.

Tso IF, Mui ML, Taylor SF, Deldin PJ. (2012). Eye-contact perception in schizophrenia: Relationship with symptoms and socio-emotional functioning. Journal of Abnormal Psychology, 121(3):616-627.

Tso IF, Grove TB, Taylor SF. (2012). Self-assessment of psychological stress in schizophrenia: Preliminary reliability and validity. Psychiatry Research, 195:39-44.

Wechter A, Gardner KN, Grove TB, Ellingrod VL (2012). Schizophrenia and folate pharmacogenetics: Review of the literature regarding folic acid and its pharmacogenetically regulated metabolism in relation to schizophrenia treatments. Mental Health Clinician, 1(9), 225-229.


Ellingrod VL, Taylor SF, Brok RD, Evans SJ, Zoellner SK, Grove TB, Bly MJ, Pop-Busui R, Dalack G. (2011). Dietary, Lifestyle and Pharmacogenetic Factors Associated with Arteriole Endothelial‑Dependent Vasodilatation In Schizophrenia Patients Treated with Atypical Antipsychotics (AAPs). Schizophrenia Research, 130:20-26. PMCID: PMC3139795.


Tso IF, Chun J, Deldin PJ (2010). Schizoaffective disorder, in Weiner IB, Craighead WE (eds): The Corsini Encyclopedia of Psychology (4th ed.), Wiley, Hoboken, NJ, pp 1499-1501.

Tso IF, Grove TB, Taylor SF. (2010). Emotional experience predicts social adjustment independent of neurocognition and social cognition in schizophrenia. Schizophrenia Research, 122:156-163.

Welsh RC, Chen AC, Taylor SF. (2010). Low frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in schizophrenia. Schizophrenia Bulletin, 36:713-722. PMCID: PMC2894601.